McKesson (MCK) stock earns a BUY rating as it excels in tech-driven healthcare, specialty growth, and strong earnings ...

McKesson (MCK) is a 'Buy' with high-growth potential in healthcare services. Learn key risks and outlook for stock ...

New study shows significant improvements in patient treatment adherence with Lumata Health’s Continuous Care model. More than 90% of people with vision impairment have a preventable or treatable cause ...

I've spent years testing clunky glasses that don't live up to their promises, but Meta's latest might finally deliver on the dream of AR eyewear.

McKesson MCK is making a strategic shift that will redefine its role in the healthcare ecosystem. Long known as one of the largest pharmaceutical distributors in North America, the company is now ...

It’s not difficult to decipher what the whiz kids of Greater Fenway want — a return on their money, even though not a dime ...

On the outskirts of Nashville, on the peaceful shores of Old Hickory Lake, sits a 6,005-square-foot home that redefines what ...

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across ...

Elon Musk is brilliant, but he also has fortunate timing. That’s because leaving technological advances aside, his electric vehicle vision likely wouldn't have taken flight in the 1980s and 1990s.